Summary & Overview
HCPCS Q1005: New Technology Intraocular Lens, Category 5
HCPCS Level II code Q1005 designates a Category 5 new-technology intraocular lens approved via Federal Register guidance. The code enables distinct identification of novel intraocular lens products used during cataract surgery or related ophthalmic procedures and supports payers and providers in tracking utilization, coverage determinations, and payment policy for emerging lens technologies. Nationally, an explicit HCPCS Level II code matters for claims processing, coverage policies, and manufacturer reporting for novel devices entering the market.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, typical service settings, and what to expect in payer coverage approaches. The publication outlines common modifiers associated with device and procedure billing (listed separately), discusses how payers may address new-technology lens claims, and highlights benchmarking and policy considerations relevant to national coverage and reimbursement. This resource is intended to inform billing staff, policy analysts, and revenue managers about the role of Q1005 in claims workflows and payer communications.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service-line specifics beyond the description provided.
Billing Code Overview
HCPCS Level II code Q1005 denotes a new technology intraocular lens, category 5, as defined in the Federal Register notice. This code identifies a surgically implanted lens that uses new or novel technology for visual rehabilitation following cataract extraction or other qualifying ophthalmic procedures.
Service type: Intraocular lens implantation (new technology category 5)
Typical site of service: Hospital outpatient department or ambulatory surgery center, aligned with settings where intraocular lens implantation procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with visually significant cataract elects refractive cataract surgery with implantation of a new-technology intraocular lens (IOL) classified under HCPCS Level II code Q1005 (New technology intraocular lens category 5 as defined in federal register notice). The typical workflow begins with preoperative evaluation by an ophthalmologist or cataract surgeon that includes history, manifest refraction, slit-lamp exam, biometry (axial length, keratometry), corneal topography, and discussion of lens options. On the day of surgery, standard phacoemulsification cataract extraction is performed in an ambulatory surgery center or hospital outpatient setting, followed by implantation of the category 5 IOL. Immediate postoperative care includes topical antibiotics and steroids, and scheduled follow-ups at postoperative day 1, week 1, and month 1 to monitor visual acuity, intraocular pressure, and wound integrity. Typical patient scenarios include patients seeking enhanced intermediate/near vision, extended depth-of-focus, or other novel optical properties offered by a category 5 IOL. Billing uses Q1005 for the device; surgical services are billed separately by CPT codes for cataract extraction and related procedures. Common modifiers applied to the device or associated professional services include AS (physician assistant or advanced practice clinician service), 62 (two surgeons), 22 (increased procedural service), 23 (unusual anesthesia), and waiver/modifier combinations for implants or patient circumstances. Typical sites of service are Ambulatory Surgery Center (ASC), Hospital Outpatient Department, and occasionally office-based surgical suites for centers meeting state and payer requirements.